Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 12:06 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Penny Stock Picks » Strong Buy: IGXT (Mcap $29 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013



Reply
 
Thread Tools Search this Thread
Old 12-27-2012, 07:34 AM   Nav to Top  #1
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 257
Favorites: Aapl celg onxx
Rep Power: 106
Reputation: 36
Biohero is on a distinguished road
Default IGXT (Mcap $29 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013

THIS UNKNOWN GEM IS DEFINITELY THE CHEAPEST STOCK IN THE BIOTECH SECTOR .PLEASE DO YOUR OWN DD AND REALIZE THE MEGA MONSTER POTENTIAL GLTA

Intelgenx launched their first drug Forfivo in October this will push this unknown Gem into Profitability by mid 2013 because of its very low burn-rate of $1.2 Mil a year !

2x New NDA filings for Migraine and Erectile Dysfunction indication in early 2013 . This Goldmine has 9x Drugs in their Mega Pipeline which will be all on the Market within next 2-3 years (see pipeline chart below) !

IGXT has NO DEBT and current Market cap of only $29 M is really a BIG BIG BARGAIN .

My Target is $8-12 within 2 Years .GLTA


Intelgenx (IGXT.OB)

Market Cap : $ 29 M
Cash: $ 3 M ( Burn-rate only $1.2 M a year )
Price : 0.59 $

Shares Out : 50 M ( 26 M shares are held by Insiders + Institutions)


Fantastic Prodcut Pipeline
http://intelgenx.com/_assets/pdf/pipelinechart.pdf


Latest Presentation Oct 2012
http://de.slideshare.net/ViralNetwor...sentation-2012


Big Buying by Institutions
http://finance.yahoo.com/q/it?s=IGXT...r+Transactions



Analyst Coverage:

IGXT gets 18 month $3.00 Price Target from AEGIS CAPITAL CORP on October 5th, 2012
http://image.slidesharecdn.com/aegis...jpg?1349900345


The Event- Forfivo XL is now officially launched in the US
http://seekingalpha.com/instablog/19...the-next-stage


IntelGenx striving to create a second Biovail
http://biotuesdays.com/2012/07/10/in...econd-biovail/




IntelGenx to file anti-migraine NDA in first 2013

IntelGenx’s anti-migraine VersaFilm is undergoing a pivotal stability study, with a 505(b)(2) new drug application expected to be filed with the FDA in the first quarter of 2013, the company says in its second quarter report.

In May, IntelGenx announced positive pivotal study results for the anti-migraine product, demonstrating that it is bioequivalent to Merck’s orally disintegrating tablet Maxalt-MLT. Sales of Maxalt-MLT grew 16% to $639-million in 2011.

IntelGenx developed the anti-migraine product under a co-development and commercialization agreement with RedHill Biopharma of Israel. In addition to milestone payments, Intelgenx is entitled to receive a share of all proceeds including, but not limited to, all sales milestones and income from the product world-wide.

“We were very busy throughout the second quarter with supporting the manufacturing activities and preparation of launch activities for Forfivo XL, which we anticipate will occur later in the third quarter,” CEO Dr. Horst Zerbe said in the quarterly report.

In addition to launch and sales milestones in the U.S. from marketing partner Edgemont Pharmaceuticals, IntelGenx will receive double-digit royalties on the net sales of Forfivo XL.

Forfivo XL is a novel, high strength formulation of bupropion HCl, the active ingredient in Wellbutrin XL. When launched, Forfivo will provide high-dose bupropion XL patients with the opportunity to achieve their entire daily dose in a single pill versus the multiple pills they currently need to take.

Reducing the number of tablets per dose significantly increases patient compliance and reduces the chance of an accidental overdose. These two factors are recognized as well-published and important clinical benefits, IntelGenx noted.
Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: IGXT (Mcap $31 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013 Biohero US Penny Stock Picks 0 12-30-2012 07:57 PM
Strong Buy: SUPN = 2x MEGA DRUGS APPROVED // 1x BLOCKBUSTER IN P3 // LOW FLOAT 5 M = 500%++ POTEN Biohero US Stock Picks 0 12-03-2012 08:50 AM
Strong Buy: PATH (MCAP $45 M) BLOCKBUSTER APPROVAL ON JAN.17 2013 = 5 BAGGER HERE Biohero US Stock Picks 0 11-29-2012 10:06 AM
Strong Buy: (IGXT)Mcap 28 M// Partnership THIS MONTH/1x Approved drug Biohero US Penny Stock Picks 0 01-26-2012 07:55 AM
Strong Buy: Viagra Spray-NDA in 4Q11 (Mcap 5 M)= 10 BAGGER biotechmaster US Penny Stock Picks 2 04-07-2011 12:50 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On